Related Experiment Video
Updated: Jul 14, 2026
07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Mitochondrial genetic background modifies breast cancer risk
Ren-Kui Bai1, Suzanne M Leal, Daniel Covarrubias
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Cancer Research
|May 19, 2007
Summary
Mitochondrial DNA variations influence breast cancer risk. Specific single nucleotide polymorphisms (SNPs) and haplogroups, like K and U, were found to significantly increase or decrease susceptibility, respectively, highlighting the role of mitochondrial genetics.
Area of Science:
- Genetics
- Oncology
- Mitochondrial Biology
Background:
- Mitochondrial electron transport chain (ETC) dysfunction is linked to reactive oxygen species (ROS) production, potentially increasing the risk of diseases like cancer.
- Mitochondrial DNA (mtDNA) variations may impact ETC efficiency and ROS levels, thereby influencing cancer susceptibility.
Purpose of the Study:
- To investigate the association between specific mitochondrial DNA (mtDNA) variations and the risk of developing familial breast cancer.
- To determine if genetic variations in mtDNA contribute to the observed predisposition to breast cancer in European-American females.
Main Methods:
- Genotyping of 69 mtDNA variations in 156 European-American females with familial breast cancer and 260 age-matched controls.
- Statistical analysis including Fisher's exact test, permutation testing for adjusted p-values, and calculation of odds ratios (OR) with 95% confidence intervals (95% CI) using the Sheehe correction.
Main Results:
- Twenty-nine out of 69 mtDNA variations were detected. Three SNPs (G9055A, A10398G, T16519C) were associated with increased breast cancer risk, while two SNPs (T3197C, G13708A) showed a decreased risk.
- Haplogroup K was significantly associated with an increased risk of breast cancer (OR, 3.03; P = 0.0057 adjusted).
- Haplogroup U was significantly associated with a decreased risk of breast cancer (OR, 0.37; P = 0.03 adjusted).
Conclusions:
- Mitochondrial DNA variations play a role in modifying an individual's susceptibility to breast cancer.
- Specific mtDNA haplogroups (K and U) are significantly linked to either increased or decreased breast cancer risk, respectively.
- These findings underscore the importance of mitochondrial genetic background in cancer etiology.
Related Concept Videos
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
02:30Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...